Ab Index-Nr. 017-019-00-5

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
017-019-00-5(R)-1,2,3,4-tetrahydro-6,7-di­methoxy-1-veratryl­iso­quino­line hydrochloride415-110-854417-53-7Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
017-020-00-0ethyl propoxy aluminium chloride421-790-713014-29-4Water-react. 1
Skin Corr. 1A
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014  
017-021-00-6behenamidopropyl-dimethyl-(di­hydroxy­propyl) ammonium chloride423-420-1136920-10-0Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H318
H317
H410
   
017-023-00-7[phosphinyldynetris(oxy)] tris[3-
aminopropyl-2-hydroxy-N,N-
dimethyl-N-(C6-18)-alkyl] trichlorides
425-520-9197179-61-6Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
017-026-00-3chlorine dioxide233-162-810049-04-4Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
H270
H330
H314
H400
GHS04
GHS03
GHS06
GHS05
GHS09
Dgr
H270
H330
H314
H400
 M = 105
017-026-01-0chlorine dioxide ... %233-162-810049-04-4Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H301
H314
H400
GHS06
GHS05
GHS09
Dgr
H301
H314
H400
 Skin Corr. 1B;
H314: C ≥ 5 %
Skin Irrit. 2;
H315: 1 % ≤ C < 5 %
Eye Dam. 1;
H318: 3 % ≤ C < 5 %
Eye Irrit. 2;
H319: 0,3 % ≤ C < 3 %
STOT SE 3;
H335: C ≥ 3 %
M = 10
B
019-001-00-2potassium231-119-87440-09-7Water-react. 1
Skin Corr. 1B
H260
H314
GHS02
GHS05
Dgr
H260
H314
EUH014  
019-002-00-8potassium hydroxide;
caustic potash
215-181-31310-58-3Acute Tox. 4 *
Skin Corr. 1A
H302
H314
GHS05
GHS07
Dgr
H302
H314
 Skin Corr. 1A;
H314: C ≥ 5 %
Skin Corr. 1B;
H314: 2 % ≤ C < 5 %
Skin Irrit. 2;
H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
 
019-003-00-3Kalium-(E,E)-hexa-2,4-dienoat246-376-124634-61-5Eye Irrit. 2H319GHS07
Wng
H319   
020-001-00-Xcalcium231-179-57440-70-2Water-react. 2H261GHS02
Dgr
H261   
020-002-00-5calcium cyanide209-740-0592-01-8Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H300
H400
H410
GHS06
GHS09
Dgr
H300
H410
EUH032  
020-003-00-0reaction mass of: dicalcium (bis(2-hydroxy-
5-tetra-propenylphenyl­methyl)methylamine)
dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenyl­phenylmethyl)methyl­amine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl­phenyl­methyl)methyl­amine)hydroxide]
420-470-4Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
   
022-001-00-5titanium tetrachloride231-441-97550-45-0Skin Corr. 1BH314GHS05
Dgr
H314EUH014  
022-002-00-0titanium(4+) oxalate403-260-7Eye Dam. 1H318GHS05
Dgr
H318   
022-003-00-6bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyr­rol-1-yl]-phenyl)titanium412-000-1125051-32-3Flam. Sol. 1
Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H228
H361f ***
H373 **
H411
GHS02
GHS08
GHS09
Dgr
H228
H361f ***
H373 **
H411
  T
022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc. 2H351GHS08
Wng
H351   
022-005-00-7[N-(1,1-dimethylethyl)-1,1-di­methyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetra­methyl-2,4-cyclo­pentadien-1-yl]silanami­nato(2-)-κN][(1,2,3,4-η)-1,3-penta­diene]-titanium419-840-8169104-71-6Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4
H228
H314
H317
H413
GHS02
GHS05
GHS07
Dgr
H228
H314
H317
H413
   
023-001-00-8divanadium pentaoxide;
vanadium pentoxide
215-239-81314-62-1Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Chronic 2
H341
H361d ***
H372 **
H332
H302
H335
H411
GHS08
GHS07
GHS09
Dgr
H341
H361d ***
H372 **
H332
H302
H335
H411
   
024-001-00-0chromium (VI) trioxide215-607-81333-82-0Ox. Sol. 1
Carc. 1A
Muta. 1B
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H410
 STOT SE 3;
H335: C ≥ 1 %
 
024-002-00-6potassium dichromate231-906-67778-50-9Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
 STOT SE 3;
H335: C ≥ 5 %
3
024-003-00-1ammonium dichromate232-143-17789-09-5Ox. Sol. 2 ****
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS03
GHS06
GHS08
GHS05
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
 STOT SE 3;
H335: C ≥ 5 %
Resp. Sens.;
H334: C ≥ 0,2 %
Skin Sens.; H317:
C ≥ 0,2 %
G 3
024-004-00-7sodium dichromate234-190-310588-01-9Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350
H340
H360FD
H330
H301
H312
H372 **
H314
H334
H317
H400
H410
GHS03
GHS06
GHS05
GHS08
GHS09
Dgr
H272
H350
H340
H360FD
H330
H301
H312
H372 **
H314
H334
H317
H410
 Resp. Sens. 1;
H334: C ≥ 0,2 %
Skin Sens. 1;
H317:
C ≥ 0,2 %
STOT SE 3;
H335: C ≥ 5 %
3
024-005-00-2chromyl dichloride;
chromic oxychloride
239-056-814977-61-8Ox. Liq. 1
Carc. 1B
Muta. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350i
H340
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Dgr
H271
H350i
H340
H314
H317
H410
 Skin Corr. 1A;
H314: C ≥ 10 %
Skin Corr. 1B;
H314: 5 % ≤ C < 10 %
Skin Irrit. 2;
H315: 0,5 % ≤ C < 5%
Eye Irrit. 2; H319:
0,5 % ≤ C < 5 %
STOT SE 3;
H335: 0,5 % ≤ C < 5%
Skin Sens. 1;
H317: C ≥ 0,5 %
T 3
024-006-00-8potassium chromate232-140-57789-00-6Carc. 1B
Muta. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H340
H319
H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H340
H319
H335
H315
H317
H410
 Skin Sens. 1;
H317: C ≥ 0.5 %
3
024-007-00-3zinc chromates including zinc potassium
chromate
Carc. 1A
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H317
H410
  A
024-008-00-9calcium chromate237-366-813765-19-0Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
   
024-009-00-4strontium chromate232-142-67789-06-2Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H400
H410
   
024-010-00-Xdichromium tris(chromate);
chromium III chromate;
chromic chromate
246-356-224613-89-6Ox. Sol. 1
Carc. 1B
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H271
H350
H314
H317
H400
H410
GHS03
GHS08
GHS05
GHS07
GHS09
Dgr
H271
H350
H314
H317
H410
  T
024-011-00-5ammonium bis(1-(3,5-dinitro-2-oxidophe-
nylazo)-3-(N-phenylcarbamoyl)-2-naphtho-
lato)chromate(1-)
400-110-2109125-51-1Self-react. C ****
Aquatic Acute 1
Aquatic Chronic 1
H242
H400
H410
GHS02
GHS09
Dgr
H242
H410
   
024-012-00-0trisodium bis(7-acetamido-2-(4-nitro-2-oxi-
dophenylazo)-3-sulphonato-1-naphtholato)
chromate(1-)
400-810-8Muta. 2H341GHS08
Wng
H341   
024-013-00-6trisodium (6-anilino-2-(5-nitro-2-oxidophe-
nylazo)-3-sulphonato-1-naphtholato)(4-sul-
phonato-1,1'-azodi-2,2'naphtholato)chro-
mate(1-)
402-500-8Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
024-014-00-1trisodium bis(2-(5-chloro-4-nitro-2-oxido-
phenylazo)-5-sulphonato-1-naphtholato)
chromate(1-)
402-870-093952-24-0Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
024-015-00-7disodium (3-methyl-4-(5-nitro-2-oxidophe-
nylazo)-1-phenylpyrazololato)(1-(3-nitro-2-
oxido-5-sulfonatophenylazo)-2-naphtho-
lato)chromate(1-)
404-930-1Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H332
H318
H411
GHS05
GHS07
GHS09
Dgr
H332
H318
H411
   
024-016-00-2tetradecylammonium bis(1-(5-chloro-2-oxi-
dophenylazo)-2-naphtholato)chromate(1-)
405-110-688377-66-6STOT RE 2 *
Aquatic Chronic 4
H373 **
H413
GHS08
Wng
H373 **
H413
   
024-017-00-8Chromium (VI) compounds, with the
exception of barium chromate and of
compounds specified elsewhere in this
Annex
Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H317
H410
  A
024-018-00-3sodium chromate231-889-57775-11-3Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410
 Resp. Sens.;
H334: C ≥ 0,2 %
Skin Sens.; H317:
C ≥ 0,2 %
3
024-019-00-9Main component: acetoacetic acid anilide/3-
amino-1-hydroxybenzene (ATAN-MAP): tri-
sodium {6-[(2 or 3 or 4)-amino-(4 or 5 or
6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-
3-sulfonatonaphthalene-2-azobenzene-1,2'-
diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-
5'''-(phenylsulfamoyl)-3''-sulfonatonaphtha-
lene-2''-azobenzene-1'',2'''-diolato}chromate
(III);
by-product 1: acetoacetic acid anilide/ace-
toacetic acid anilide (ATAN-ATAN): triso-
dium bis{6-[1-(phenylcarbamoyl)ethylazo]-
5'-(phenylsulfonyl)-3-sulfonatonaphthalene-
2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/
3-amino-1-hydroxybenzene (MAP-MAP):
trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5
or 6)-hydroxyphenylazo]-5'-(phenylsulfa-
moyl)-3-sulfonatonaphthalene-2-azoben-
zene-1,2'-diolato} chromate (III)
419-230-1Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
024-020-00-4trisodium
bis[(3'-nitro-5'-sulfonato(6-
amino-2-[4-(2-hydroxy-1-
naphtylazo)phe-
nylsulfonylamino]pyrimidin-5-
azo)benzene-
2',4-diolato)]chromate(III)
418-220-4Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
024-021-00-Xpotassium tetrasodium
bis[(N,N´-n)-1´-(phenylcarba-
moyl)-3,5-disulfonatobenze-
neazo-1´-prop-1´-ene-2,2´-
diolato]chromate(III)
425-830-4Eye Dam. 1H318GHS05
Dgr
H318   
025-001-00-3manganese dioxide215-202-61313-13-9Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
   
025-002-00-9potassium permanganate231-760-37722-64-7Ox. Sol. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H410
   
025-003-00-4manganese sulphate232-089-97785-87-7STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
   
025-004-00-Xbis(N,N',N''-trimethyl-1,4,7-triazacyclono-
nane)-trioxo-dimanganese (IV) di(hexafluo-
rophosphate) monohydrate
411-760-1116633-53-5Aquatic Chronic 2H411GHS09H411   
025-005-00-5reaction mass of: tri-sodium [29H, 31H-
phthalocyanine-C,C,C-trisulfonato (6-)-N29,
N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,
C,C-tetrasulfonato (6-)-N29,N30,N31,N32],
manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,
C,C,C,C-pentasulfonato (6-)-N29,N30,N31,
N32] manganate (3-)
417-660-4Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
026-001-00-6(η-cumene)-(η-cyclopentadienyl)iron(II)
hexafluoroantimonate
407-840-0100011-37-8Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
026-002-00-1(η-cumene)-(η-cyclopentadienyl)iron(II) trif-
luoromethane-sulfonate
407-880-9117549-13-0Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
026-003-00-7iron (II) sulfate231-753-57720-78-7Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
   
026-003-01-4iron(II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate
231-753-57782-63-0Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
H302
H319
H315
GHS07
Wng
H302
H319
H315
 Skin Irrit. 2; H315:
C ≥ 25 %
 
026-004-00-2potassium ferrite430-010-412160-44-0Skin Corr. 1B
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
   
027-001-00-9cobalt231-158-07440-48-4Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4
H334
H317
H413
GHS08
Dgr
H334
H317
H413
   
027-002-00-4cobalt oxide215-154-61307-96-6Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
 M = 10 
027-003-00-Xcobalt sulfide215-273-31317-42-6Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
 M = 10 
027-004-00-5cobalt dichloride231-589-47646-79-9Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F ***
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F ***
H302
H334
H317
H410
 Carc. 1B;
H350i:
C ≥ 0,01 %
M = 10
1
027-005-00-0cobalt sulfate233-334-210124-43-3Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F ***
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360F ***
H302
H334
H317
H410
 Carc. 1B;
H350i:
C ≥ 0,01 %
M = 10
1
027-006-00-6cobalt di(acetate)200-755-871-48-7Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F ***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F ***
H334
H317
H410
 Carc. 1B; H350i:
C ≥ 0,01 %
M = 10
1
027-007-00-1zinc hexacyanocobaltate(III), tertiary
butyl alcohol/polypropylene glycol complex
425-240-7Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
027-008-00-7complex of cobalt(III)-
bis(N-phenyl-4-(5-ethylsulfonyl-
2-hydroxyphenylazo)-3-
hydroxynaphthylamide), hydrated
(n H2O, 2 < n < 3)
427-390-9Skin Sens. 1H317GHS07
Wng
H317   
027-009-00-2cobalt dinitrate233-402-110141-05-6Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F ***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F ***
H334
H317
H410
 Carc. 1B; H350i:
C ≥ 0,01 %
M = 10
1
027-010-00-8cobalt carbonate208-169-4513-79-1Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360F ***
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360F ***
H334
H317
H410
 Carc. 1B; H350i:
C ≥ 0,01 %
M = 10
1
028-001-00-1tetracarbonylnickel;
nickel tetracarbonyl
236-669-213463-39-3Flam. Liq. 2
Carc. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1
H225
H351
H360D ***
H330
H400
H410
GHS02
GHS06
GHS08
GHS09
Dgr
H225
H351
H360D ***
H330
H410
   
028-002-00-7nickel231-111-47440-02-0Carc. 2
STOT RE 1
Skin Sens. 1
H351
H372 **
H317
GHS08
GHS07
Dgr
H351
H372 **
H317
  S 7
028-002-01-4nickel powder;
[particle diameter < 1 mm]
231-111-47440-02-0Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3
H351
H372 **
H317
H412
GHS08
GHS07
Dgr
H351
H372 **
H317
H412
   
028-003-00-2nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]
215-215-7 [1]
234-323-5 [2]
- [3]
1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372 **
H317
H413
GHS08
GHS07
Dgr
H350i
H372 **
H317
H413
   
028-004-00-8nickel dioxide234-823-312035-36-8Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372 **
H317
H413
GHS08
GHS07
Dgr
H350i
H372 **
H317
H413
   
028-005-00-3dinickel trioxide215-217-81314-06-3Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4
H350i
H372 **
H317
H413
GHS08
GHS07
Dgr
H350i
H372 **
H317
H413
   
028-006-00-9nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]
240-841-2 [1]
234-349-7 [2]
- [3]
16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372 **
H317
H410
   
028-007-00-4trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]
234-829-6 [1]
- [2]
12035-72-2 [1]
12035-71-1 [2]
Carc. 1A
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H372 **
H317
H410
   
028-008-00-Xnickel dihydroxide; [1]
nickel hydroxide [2]
235-008-5 [1]
234-348-1 [2]
12054-48-7 [1]
11113-74-9 [2]
Carc. 1A
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360D ***
H341
H372 **
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360D ***
H341
H372 **
H332
H302
H315
H334
H317
H410
   
028-009-00-5nickel sulfate232-104-97786-81-4Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H332
H302
H315
H334
H317
H410
 STOT RE 1;
H372: C ≥ 1 %
STOT RE 2;
H373: 0,1 % ≤
C < 1 %
Skin Irrit. 2;
H315: C ≥
20 %
Skin Sens. 1;
H317:
C ≥ 0,01 %
M = 1
 
028-010-00-0nickel carbonate;
basic nickel carbonate;
carbonic acid, nickel (2+) salt; [1]
carbonic acid, nickel salt; [2]
[μ-[carbonato(2-)-O:O´]] dihydroxy
trinickel; [3]
[carbonato(2-)] tetrahydroxytrinickel [4]
222-068-2 [1]
240-408-8 [2]
265-748-4 [3]
235-715-9 [4]
3333-67-3 [1]
16337-84-1 [2]
65405-96-1 [3]
12607-70-4 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H332
H302
H315
H334
H317
H410
   
028-011-00-6nickel dichloride231-743-07718-54-9Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H331
H301
H372 **
H315
H334
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H331
H301
H372 **
H315
H334
H317
H410
 STOT RE. 1; H372:
C ≥ 1 %
STOT RE. 2; H373:
0,1 % < C < 1 %
Skin Irrit. 2; H315:
C ≥ 20 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-012-00-1nickel dinitrate; [1]
nitric acid, nickel salt [2]
236-068-5 [1]
238-076-4 [2]
13138-45-9 [1]
14216-75-2 [2]
Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H272
H350i
H341
H360D ***
H372 **
H332
H302
H318
H315
H317
H400
H410
GHS03
GHS05
GHS08
GHS07
GHS09
Dgr
H272
H350i
H341
H360D ***
H372 **
H332
H302
H318
H315
H317
H410
 STOT RE. 1; H372:
C ≥ 1 %
STOT RE. 2; H373:
0,1 % < C < 1 %
Skin Irrit. 2; H315:
C ≥ 20 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-013-00-7nickel matte273-749-669012-50-6Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-014-00-2slimes and sludges, copper
electrolytic refining, decopperised,
nickel sulfate
295-859-392129-57-2Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H332
H302
H315
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H332
H302
H315
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-015-00-8slimes and sludges, copper electrolyte refining, decopperised305-433-194551-87-8Carc. 1A
Muta. 2
Repr. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
   
028-016-00-3nickel diperchlorate;
perchloric acid, nickel(II) salt
237-124-113637-71-3Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H314
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-017-00-9nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H332
H302
H334
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H332
H302
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-018-00-4nickel bis(sulfamidate);
nickel sulfamate
237-396-113770-89-3Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-019-00-Xnickel bis(tetrafluoroborate)238-753-414708-14-6Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-021-00-0nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-022-00-6nickel di(acetate); [1]
nickel acetate [2]
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H332
H302
H334
H317
H400
H410
GHS08
GHS07
Dgr
H350i
H341
H360D ***
H372 **
H332
H302
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-024-00-7nickel dibenzoate209-046-8553-71-9Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-025-00-2nickel bis(4-cyclohexylbutyrate)223-463-23906-55-6Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-026-00-8nickel(II) stearate;
nickel(II) octadecanoate
218-744-12223-95-2Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-027-00-3nickel dilactate16039-61-5Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-028-00-9nickel(II) octanoate225-656-74995-91-9Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H314
H334
H317
H400
H410
GHS05
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H314
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-029-00-4nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-030-00-Xnickel hexafluorosilicate247-430-726043-11-8Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-031-00-5nickel selenate239-125-215060-62-5Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-032-00-0nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372 **
H334
H317
H410
   
028-033-00-6diammonium nickel hexacyanoferrate74195-78-1Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372 **
H334
H317
H410
   
028-034-00-1nickel dicyanide209-160-8557-19-7Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372 **
H334
H317
H410
EUH032  
028-035-00-7nickel chromate238-766-514721-18-7Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372 **
H334
H317
H410
   
028-036-00-2nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen
hydroxybis[orthosilicato(4-)]
trinickelate(3-) [5]
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-037-00-8dinickel hexacyanoferrate238-946-314874-78-3Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-038-00-3trinickel bis(arsenate);
nickel(II) arsenate
236-771-713477-70-8Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H372 **
H317
H410
   
028-039-00-9nickel oxalate; [1]
oxalic acid, nickel salt [2]
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-040-00-4nickel telluride235-260-612142-88-0Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-041-00-Xtrinickel tetrasulfide12137-12-1Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-042-00-5trinickel bis(arsenite)74646-29-0Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-043-00-0cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
269-051-6 [1]
261-346-8 [2]
- [3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372 **
H317
GHS08
GHS07
Dgr
H350i
H372 **
H317
   
028-044-00-6nickel tin trioxide;
nickel stannate
234-824-912035-38-0Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372 **
H317
GHS08
GHS07
Dgr
H350i
H372 **
H317
   
028-045-00-1nickel triuranium decaoxide239-876-615780-33-3Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372 **
H317
GHS08
GHS07
Dgr
H350i
H372 **
H317
   
028-046-00-7nickel dithiocyanate237-205-113689-92-4Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
EUH032STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-047-00-2nickel dichromate239-646-515586-38-6Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-048-00-8nickel(II) selenite233-263-710101-96-9Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372 **
H334
H317
H410
   
028-049-00-3nickel selenide215-216-21314-05-2Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-050-00-9silicic acid, lead nickel salt68130-19-8Carc. 1A
Repr. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H360Df
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H360Df
H372 **
H317
H410
   
028-051-00-4nickel diarsenide; [1]
nickel arsenide [2]
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-052-00-Xnickel barium titanium primrose
priderite;
C.I. Pigment Yellow 157;
C.I. 77900
271-853-668610-24-2Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372 **
H317
GHS08
GHS07
Dgr
H350i
H372 **
H317
   
028-053-00-5nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317:
C ≥ 0,01 %
M = 1
 
028-054-00-0nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O1,O2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-
hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-
O)nickel; [21]
(isononanoato-O)(isooctanoato-
O)nickel; [22]
(isooctanoato-O)(neodecanoato-
O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-
O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-
O)nickel; [25]
(isodecanoato-O)(isooctanoato-
O)nickel; [26]
(isodecanoato-O)(isononanoato-
O)nickel; [27]
(isononanoato-O)(neodecanoato-
O)nickel; [28]
fatty acids, C6-19-branched, nickel
salts; [29]
fatty acids, C8-18 and C18-unsaturated,
nickel salts; [30]
2,7-naphthalenedisulfonic acid,
nickel(II) salt; [31]
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H341
H360D ***
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H341
H360D ***
H372 **
H334
H317
H410
 STOT RE 1; H372:
C ≥ 1 %
STOT RE 2; H373:
0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C
≥ 0,01 %
M = 1
 
028-055-00-6nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide
phosphate [4]
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H334
H317
H400
H410
GHS08
GHS09
Dgr
H350i
H372 **
H334
H317
H410
   
028-056-00-1nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H372 **
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H350i
H372 **
H317
H410
   
028-057-00-7dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1
[10]
12673-58-4
[11]
Carc. 1A
STOT RE 1
Skin Sens. 1
H350i
H372 **
H317
GHS08
GHS07
Dgr
H350i
H372 **
H317
   
028-058-00-2cobalt lithium nickel oxide442-750-5Carc. 1A
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350i
H330
H372 **
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H350i
H330
H372 **
H317
H410